Curie Cancer
The EpCART Program
The EpCART program is a flagship example of CellAction’s capabilities in translating cutting-edge science into clinical innovation.
Explore the offer and full use caseI2C
API-FLOW-CRIST: continuous-flow synthesis and crystallization of ibuprofen
CARMeN and SMS laboratories at Carnot i2C demonstrated the feasibility of coupling continuous-flow synthesis and crystallization of ibuprofen and its sodium salt, Na-Ibu, to optimize and intensify pharmaceutical processes.
Explore the offer and full use caseI2C
High-resolution mass spectrometry imaging
The MALDI-FTICR imaging approach developed by CARMeN at Carnot i2C can locate and quantify anticancer molecules such as carboplatin and temozolomide, and contrast agents such as Dotarem, in biological tissues, including mouse and pig brain sections.
Explore the offer and full use caseI2C
Biomaterials for regeneration and tissue engineering
Carnot i2C develops bioinspired heterogeneous macromolecular scaffolds for tissue regeneration, controlling the three-dimensional architecture of biomaterials.
Explore the offer and full use case